Gene:
CYP2B6
cytochrome P450, family 2, subfamily B, polypeptide 6

PharmGKB contains no dosing guidelines for this gene. To report known dosing guidelines, or if you are interested in developing guidelines, click here.

PharmGKB contains no drug labels with pharmacogenomic information for this gene. To report a drug label with PGx, click here.

PharmGKB contains no Clinical Variants that meet the highest level of criteria.

To see more Clinical Variants with lower levels of criteria, click the button at the bottom of the table.

Position ? Drug ? Relevance ? Strength of
Evidence ?
rs2279343 more likely to cause oral mucositis 2
rs8192709 more likely to cause hemorrhagic cystitis 3

Download a summary of all Clinical Annotations available.

Disclaimer: The PharmGKB's clinical annotations reflect expert consensus based on clinical evidence and peer-reviewed literature available at the time they are written and are intended only to assist clinicians in decision-making and to identify questions for further research. New evidence may have emerged since the time an annotation was submitted to the PharmGKB. The annotations are limited in scope and are not applicable to interventions or diseases that are not specifically identified.

The annotations do not account for individual variations among patients, and cannot be considered inclusive of all proper methods of care or exclusive of other treatments. It remains the responsibility of the health-care provider to determine the best course of treatment for a patient. Adherence to any guideline is voluntary, with the ultimate determination regarding its application to be made solely by the clinician and the patient. PharmGKB assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of the PharmGKB clinical annotations, or for any errors or omissions.

? = Mouse-over for quick help

PharmGKB contains no genetic tests for this gene. To report genetic tests, click here.

The table below contains information about pharmacogenomic variants on PharmGKB. Please follow the link in the "Variant" column for more information about a particular variant. Each link in the "Variant" column leads to the corresponding PharmGKB Variant Page. The Variant Page contains summary data, including PharmGKB manually curated information about variant-drug pairs based on individual PubMed publications. The PMIDs for these PubMed publications can be found on the Variant Page.

The tags in the first column of the table indicate what type of information can be found on the corresponding Variant Page.

Links in the "Drugs" column lead to PharmGKB Drug Pages.

Variant?
(build 132)
Alternate Names ? Drugs ? Alleles ? Function ? Amino Acid?
Translation
rs2279343 CYP2B6*4, CYP2B6:18053A>G, CYP2B6:785A>G, CYP2B6:K262R, CYP2B6:Lys262Arg, c.785A>G, g.13783481A>G, g.211437A>G, g.23060A>G, p.Lys262Arg, part of CYP2B6*6 A > G Missense Lys262Arg
rs28399499 CYP2B6: 983T>C, CYP2B6:Ile328Thr, I328T, c.983T>C, g.13786439T>C, g.214395T>C, g.26018T>C, p.Ile328Thr, part of CYP2B6*18 T > C Missense Ile328Thr
rs3211371 1459C>T, Arg487Cys, CYP2B6*5, CYP2B6*7, CYP2B6:1459C>T, CYP2B6:Arg487Cys, c.1459C>T, g.13790933C>T, g.218889C>T, g.30512C>T, p.Arg487Cys, part of CYP2B6*1C C > T Missense Arg487Cys
No VIP available No Clinical Annotations available VA
rs34097093 CYP2B6*28, CYP2B61132C>T, CYP2B6:R378X, c.1132C>T, g.13786588C>T, g.214544C>T, g.26167C>T, p.Arg378X C > T Stop Codon Arg378Xaa
No VIP available No Clinical Annotations available VA
rs34223104 -82, CYP2B6:, defining SNP of CYP2B6*22, g.13765347T>C, g.193303T>C, g.4926T>C C/T 5' Flanking
No VIP available No Clinical Annotations available VA
rs35303484 c.136A>T, g.13765564A>T, g.193520A>T, g.5143A>T, p.Met46Leu A > T Missense Met46Leu
No VIP available No Clinical Annotations available VA
rs36079186 CYP2B6*27, CYP2B6:593T>C, CYP2B6:M198T, c.593T>C, g.13781136T>C, g.20715T>C, g.209092T>C, p.Met198Thr T > C Missense Met198Thr
rs3745274 CYP2B6*6, CYP2B6:516G>T, CYP2B6:Gln172His, Q172H, c.516G>T, g.13781059G>T, g.20638G>T, g.209015G>T, p.Gln172His G > T Missense Gln172His
No VIP available No Clinical Annotations available VA
rs58425034 c.646-159G>C, g.13783183G>C, g.211139G>C, g.22762G>C C/G Intronic
No VIP available CA VA
rs8192709 CYP2B6*2, CYP2B6:64C>T, c.64C>T, g.13765492C>T, g.193448C>T, g.5071C>T, p.Arg22Cys C > T Missense Arg22Cys
Alleles, Functions, and Amino Acid Translations are all sourced from dbSNP build 132

Overview

Alternate Names:  cytochrome P450 2B6; cytochrome P450 IIB1; cytochrome P450, subfamily IIB (phenobarbital-inducible), polypeptide 6
Alternate Symbols:  CPB6; CYP2B; CYP2B7; CYP2B7P; CYPIIB6; IIB1; P450
Haplotypes: CYP2B6*1; CYP2B6*1A; CYP2B6*1B; CYP2B6*1C; CYP2B6*1D; CYP2B6*1E; CYP2B6*1F; CYP2B6*1G; CYP2B6*1H; CYP2B6*1J; CYP2B6*1K; CYP2B6*1L; CYP2B6*1M; CYP2B6*1N; CYP2B6*2; CYP2B6*2A; CYP2B6*2B; CYP2B6*3; CYP2B6*4; CYP2B6*4A; CYP2B6*4B; CYP2B6*4C; CYP2B6*4D; CYP2B6*5; CYP2B6*5A; CYP2B6*5B; CYP2B6*5C; CYP2B6*6; CYP2B6*6A; CYP2B6*6B; CYP2B6*6C; CYP2B6*7; CYP2B6*7A; CYP2B6*7B; CYP2B6*8; CYP2B6*9; CYP2B6*10; CYP2B6*11; CYP2B6*11A; CYP2B6*11B; CYP2B6*12; CYP2B6*13; CYP2B6*13A; CYP2B6*13B; CYP2B6*14; CYP2B6*15; CYP2B6*15A; CYP2B6*15B; CYP2B6*16; CYP2B6*17; CYP2B6*17A; CYP2B6*17B; CYP2B6*18; CYP2B6*19; CYP2B6*20; CYP2B6*21; CYP2B6*22; CYP2B6*23; CYP2B6*24; CYP2B6*25; CYP2B6*26; CYP2B6*27; CYP2B6*28; CYP2B6*29
PharmGKB Accession Id: PA123

Details

Cytogenetic Location: chr19 : q13.2 - q13.2
GP mRNA Boundary: chr19 : 41497204 - 41524301
GP Gene Boundary: chr19 : 41487204 - 41527301
Strand: plus
Product Name: cytochrome P450, family 2, subfamily B, polypeptide 6, cytochrome P450, subfamily IIB (phenobarbital-inducible), polypeptide 6
The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for potential regulatory regions.

All alleles are displayed on the positive chromosomal strand.

Download Haplotype Data (CSV)

Haplotype rs12721649 rs12721655 rs2279341 rs2279342 rs2279343 rs2279344 rs28399499 rs3211369 rs3211371 rs33926104 rs33973337 rs33980385 rs34097093 rs34223104 rs34284776 rs34698757 rs34826503 rs34883432 rs35010098 rs35266616 rs35303484 rs35468935 rs35622401 rs35773040 rs35979566 rs36056539 rs36060847 rs36079186 rs3745274 rs3826711 rs45482602 rs4802101 rs4803418 rs4803419 rs8192709 rs8192719
CYP2B6*1 G A G A/T A G T A C C A A C T G C C A C C A C G G T C G T G C C T/C C/G C/T C C
CYP2B6*1A G A G A A G T A C C A A C T G C C A C C A C G G T C G T G C C T C C C C
CYP2B6*1B G A G A A G T A C C A A C T G C C A C C A C G G T C G T G C C T C T C C
CYP2B6*1C G A G A A G T A C C A A C T G C C A C C A C G G T C G T G C C T G C C C
CYP2B6*1D G A G A A G T A C C A A C T G C C A C C A C G G T C G T G C C T C C C C
CYP2B6*1E G A G A A G T A C C A A C T G C C A C C A C G G T C G T G C C T C C C C
CYP2B6*1F G A G A A G T A C C A A C T G C C A C C A C G G T C G T G C C T C C C C
CYP2B6*1G G A G A A G T A C C A A C T G C C A C C A C G G T C G T G C C C C C C C
CYP2B6*1H G A G A A G T A C C A A C T G C C A C C A C G G T C G T G C C C C C C C
CYP2B6*1J G A G A A G T A C C A A C T G C C A C C A C G G T C G T G C C C C C C C
CYP2B6*1K G A G A A G T A C C A A C T G C C A C C A C G G T C G T G C C C C C C C
CYP2B6*1L G A G A A G T A C C A A C T G C C A C C A C G G T C G T G C C C C C C C
CYP2B6*1M G A G A A G T A C C A A C T G C C A C C A C G G T C G T G C C T C C C C
CYP2B6*1N G A G A A G T A C C A A C T G C C A C C A C G G T C G T G C C C C C C C
CYP2B6*2 G A G/C A A G T A C C A A C T G C C A C C A C G G T C G T G C C T C C T C
CYP2B6*2A G A G A A G T A C C A A C T G C C A C C A C G G T C G T G C C T C C T C
CYP2B6*2B G A C A A G T A C C A A C T G C C A C C A C G G T C G T G C C T C C T C
CYP2B6*3 G A G A A G T A C C A A C T G C C A C C A C G G T C G T G C A T C C C C
CYP2B6*4 G A G A/T G G T A C C A A C T G C C A C C A C G G T C G T G C C T/C C C C C
CYP2B6*4A G A G A G G T A C C A A C T G C C A C C A C G G T C G T G C C T C C C C
CYP2B6*4B G A G A G G T A C C A A C T G C C A C C A C G G T C G T G C C C C C C C
CYP2B6*4C G A G T G G T A C C A A C T G C C A C C A C G G T C G T G C C T C C C C
CYP2B6*4D G A G A G G T A C C A A C T G C C A C C A C G G T C G T G C C C C C C C
CYP2B6*5 G A G A A G T A T C A A C T G C C A C C A C G G T C G T G C C T/C C C C C
CYP2B6*5A G A G A A G T A T C A A C T G C C A C C A C G G T C G T G C C T C C C C
CYP2B6*5B G A G A A G T A T C A A C T G C C A C C A C G G T C G T G C C C C C C C
CYP2B6*5C G A G A A G T A T C A A C T G C C A C C A C G G T C G T G C C T C C C C
CYP2B6*6 G A G A G G T A C C A A C T G C C A C C A C G G T C G T T C C T/C C C C C
CYP2B6*6A G A G A G G T A C C A A C T G C C A C C A C G G T C G T T C C T C C C C
CYP2B6*6B G A G A G G T A C C A A C T G C C A C C A C G G T C G T T C C C C C C C
CYP2B6*6C G A G A G G T A C C A A C T G C C A C C A C G G T C G T T C C C C C C C
CYP2B6*7 G A G A G G T A T C A A C T G C C A C C A C G G T C G T T C C T/C C C C C
CYP2B6*7A G A G A G G T A T C A A C T G C C A C C A C G G T C G T T C C T C C C C
CYP2B6*7B G A G A G G T A T C A A C T G C C A C C A C G G T C G T T C C C C C C C
CYP2B6*8 G G G A A G T A C C A A C T G C C A C C A C G G T C G T G C C T C C C C
CYP2B6*9 G A G A A G T A C C A A C T G C C A C C A C G G T C G T T C C T C C C T
CYP2B6*10 G A C A A G T A C C A A C T G C C T C C A C G G T C G T G C C T C C T C
CYP2B6*11 G A G A A G/A T A C C A A C T G C C A C C G C G G T C G T G C C T C C C C
CYP2B6*11A G A G A A G T A C C A A C T G C C A C C G C G G T C G T G C C T C C C C
CYP2B6*11B G A G A A A T A C C A A C T G C C A C C G C G G T C G T G C C T C C C C
CYP2B6*12 G A G A A A T A C C A A C T G C C A C C A C G G T C A T G C C T C C C C
CYP2B6*13 G G G A G A T A C C A A C T G C C A C C A C G G T C G T T C C T C T/C C T
CYP2B6*13A G G G A G A T A C C A A C T G C C A C C A C G G T C G T T C C T C C C T
CYP2B6*13B G G G A G A T A C C A A C T G C C A C C A C G G T C G T T C C T C T C T
CYP2B6*14 G A G A A A T A C C A A C T G C C A C C A C G A T C G T G C C T C T C C
CYP2B6*15 G A G A A A/G T A C C A A C T G C C A C C A C G G A C G T G C C T C T C C
CYP2B6*15A G A G A A G T A C C A A C T G C C A C C A C G G A C G T G C C T C T C C
CYP2B6*15B G A G A A A T A C C A A C T G C C A C C A C G G A C G T G C C T C T C C
CYP2B6*16 G A G A G G C A C C A A C T G C C A C C A C G G T C G T G C C T C C C C
CYP2B6*17 G A G A A A T A C A T G C T C C C A C C A C/T G G T C G T G C C T C C C C
CYP2B6*17A G A G A A A T A C A T G C T C C C A C C A T G G T C G T G C C T C C C C
CYP2B6*17B G A G A A A T A C A T G C T C C C A C C A C G G T C G T G C C T C C C C
CYP2B6*18 A A G A A A C A C C A A C T G C C A C C A C G G T C G T G C C T C C C C
CYP2B6*19 G A G A G A T A C C A A C T G C T A C C A C G G T C G T T C C T C C C T
CYP2B6*20 G A G A G A T A C C A A C T G C C A C C A C G G T T G T T C C T C C C C
CYP2B6*21 G A G A A A T A C C A A C T G C C A A C A C G G T C G T G C C T C C C C
CYP2B6*22 G A G A A G T A C C A A C C G C C A C C A C G G T C G T G C C C C C C C
CYP2B6*23 G A G A A G T G C C A A C T G C C A C C A C G G T C G T G C C T C C C C
CYP2B6*24 G A G A A G T A C C A A C T G C C A C C A C G G T C G T G C C T C C C C
CYP2B6*25 G A G A A G T A C C A A C T G C C A C C A C G G T C G T G C C T C C C C
CYP2B6*26 G A G A G G T A C C A A C T G C C A C C A C G G T C G T T G C T C C C C
CYP2B6*27 G A G A A A T A C C A A C T G C C A C C A C G G T C G C G C C T C C C C
CYP2B6*28 A A G A A A T A C C A A T T G G C A C T A C C G T C G T G C C C C C C C
CYP2B6*29 G A G A A G T A C A T G C T C C C A C C A C G G T C G C T C C T C C C C

PharmGKB Curated Pathways

Pathways created internally by PharmGKB based primarily on literature evidence.

  1. Carbamazepine Pathway, Pharmacokinetics
    Stylized liver cell depicting candidate genes involved in the pharmacokinetics of carbamazepine.
  1. Clopidogrel Pathway, Pharmacokinetics
    Clopidogrel metabolism.
  1. Cyclophosphamide Pathway, Pharmacokinetics
    Model human liver cell showing genes involved in the metabolism of cyclophosphamide.
  1. Ifosfamide Pathway (PK)
    Model human liver cell showing genes involved in the metabolism of ifosfamide
  1. Nicotine Pathway, Pharmacokinetics
    Summary of nicotine metabolism in human liver cell.
  1. Phenytoin Pathway, Pharmacokinetics
    Genes involved in the metabolism of phenytoin in the human liver cell.
  1. Tamoxifen Pathway, Pharmacokinetics
    Tamoxifen metabolism in the liver.

External Pathways

Links to non-PharmGKB pathways.

  1. Xenobiotics - (Reactome via Pathway Interaction Database)

Curated Information ?

Gene Relationship Evidence
NR1I2
  •   
  •   
Publications
NR1I3
  •   
  •   
Publications

Non-Curated Information ?

A list of non-curated publications that mention this gene along with other genes is available.

Curated Information ?

Drug Class Relationship Evidence
antidepressants
  •   
  • PK
Publications
artemisinin and derivatives
  • PD
  • PK
Publications
Selective serotonin reuptake inhibitors
  •   
  • PK
Publications
vitamin d and analogues
  •   
  •   
Publications
xenobiotics
  •   
  •   
Publications
Drug Relationship Evidence
aflatoxin b1
  •   
  •   
Publications
arteether
  •   
  • PK
Pathways
artemether
  •   
  • PK
Pathways
artemisinin
  •   
  • PK
Publications, Pathways
artesunate
  •   
  • PK
Pathways
bupropion
  • PD
  • PK
Publications, Variants
caffeine
  •   
  • PK
Publications
carbamazepine
  • PD
  • PK
Publications, Pathways, Variants
clomipramine
  •   
  •   
Publications
clopidogrel
  • PD
  • PK
Publications
clozapine
  •   
  • PK
Publications
cyclophosphamide
  • PD
  • PK
Publications, Variants
cyclosporine
  • PD
  • PK
Publications
dexamethasone
  •   
  •   
Publications
docetaxel
  •   
  • PK
Publications
doxorubicin
  • PD
  •   
Publications
efavirenz
  • PD
  • PK
Publications, Variants
etoposide
  •   
  •   
Publications
exemestane
  •   
  • PK
Publications
fluorouracil
  • PD
  •   
Publications
fluphenazine
  •   
  •   
Publications
haloperidol
  •   
  •   
Publications
ibuprofen
  •   
  •   
Publications
ifosfamide
  •   
  • PK
Publications
isradipine
  •   
  •   
Publications
ketamine
  •   
  • PK
Publications
ketoconazole
  •   
  •   
Publications
meperidine
  •   
  • PK
Publications
mephenytoin
  • PD
  • PK
Publications, Variants
methadone
  • PD
  • PK
Publications
methotrexate
  • PD
  • PK
Publications
miconazole
  •   
  •   
Publications
midazolam
  •   
  •   
Publications
nelfinavir
  • PD
  • PK
Publications
nevirapine
  • PD
  • PK
Publications, Variants
nicardipine
  •   
  •   
Publications
nicotine
  •   
  • PK
Publications, Variants
nifedipine
  •   
  •   
Publications
paclitaxel
  •   
  •   
Publications
permethrin
  •   
  •   
Publications
phenobarbital
  • PD
  • PK
Publications
phenytoin
  • PD
  • PK
Publications
prasugrel
  • PD
  • PK
Publications
primaquine
  •   
  • PK
Publications
propofol
  •   
  • PK
Publications
rifampin
  • PD
  • PK
Publications
ritonavir
  • PD
  •   
Publications
selegiline
  •   
  • PK
Publications
sertraline
  •   
  •   
Publications
sibutramine
  •   
  • PK
Publications
tamoxifen
  •   
  • PK
Publications
tegafur
  •   
  •   
Publications
teniposide
  •   
  •   
Publications
thiotepa
  • PD
  • PK
Publications
ticlopidine
  •   
  • PK
Publications
tramadol
  •   
  • PK
Publications, Pathways
valproic acid
  •   
  • PK
Publications
varenicline
  • PD
  •   
Publications
warfarin
  •   
  •   
Publications

Non-Curated Information ?

A list of non-curated publications that mention this gene along with other drugs is available.

Curated Information ?

Non-Curated Information ?

A list of non-curated publications that mention this gene along with other diseases is available.

PharmGKB® is a registered trademark of HHS and is financially supported by NIH/NIGMS. It is managed at Stanford University (R24 GM61374).
©2001-2012 PharmGKB.